Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Pharmacokinetics of propentofylline and the quantitation of its metabolitehydroxypropentofylline in human volunteers
Autore:
Kwon, OS; Chung, YB; Kim, MH; Hahn, HG; Rhee, HK; Ryu, JC;
Indirizzi:
Korea,Adv Inst Sci & Technol, Bioanal & Biotransformat Res Ctr, Toxicol Lab Korea Adv Inst Sci & Technol Seoul South Korea 136790 s Ctr, Toxicol Lab Korea Adv Inst Sci & Technol, Med Chem Res Ctr, Div Appl Sci, Seoul 136790, Korea Adv Inst Sci & Technol Seoul South Korea 136790 Sci, Seoul 136790, Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea Chungbuk NatlUniv Cheongju South Korea 361763 ongju 361763, South Korea
Titolo Testata:
ARCHIVES OF PHARMACAL RESEARCH
fascicolo: 6, volume: 21, anno: 1998,
pagine: 698 - 702
SICI:
0253-6269(199812)21:6<698:POPATQ>2.0.ZU;2-O
Fonte:
ISI
Lingua:
ENG
Soggetto:
CALCIUM ACCUMULATION; HIPPOCAMPAL SLICES; ISCHEMIA; GERBIL; RAT;
Keywords:
pharmacokinetics; propentofylline; human; hydroxypropentofylline; synthesis of metabolite;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
12
Recensione:
Indirizzi per estratti:
Indirizzo: Kwon, OS Korea,Adv Inst Sci & Technol, Bioanal & Biotransformat Res Ctr, Toxicol Lab Korea Adv Inst Sci & Technol Seoul South Korea 136790 xicol Lab
Citazione:
O.S. Kwon et al., "Pharmacokinetics of propentofylline and the quantitation of its metabolitehydroxypropentofylline in human volunteers", ARCH PH RES, 21(6), 1998, pp. 698-702

Abstract

Propentofylline (PPF, 3-methyl-1-(5-oxohexyl)-7-propylxanthine) has been reported to be effective for the treatment of both vascular dementia and dementia of the Alzheimer type. The pharmacological effects of PPF may be exerted via the stimulation of nerve growth factor, increased cerebral blood flow, and inhibition of adenosine uptake. The objectives of this experiment are to determine the kinetic behavior of PPF, to identify, and to quantify its metabolite in human. Blood samples were obtained from human Volunteers following oral administration of 200 mg of PPF tablets. For the identification and quantification of the metabolite, 3-methyl-1-(5-hydroxyhexyl)-7-propylxanthine (PPFOH), PPFOH was synthesized and identified by gas chromatography/mass spectroscopy (GC/MS) and H-1-nuclear magnetic resonance spectroscopy. The molecular weight of synthesized metabolite is 308 dalton. The PPF and PPFOH in plasma were extracted with diethyl ether and identified by electron impact GC/MS. The plasma concentrations of PPF and PPFOH were determined by gas chromatography/nitrogen phosphorus detector in plasma and their pharmacokinetic parameters were determined. The mean half-life of PPF was 0.74 hr. The areas under the curve (AUCs) of PPF and PPFOH were 508 and 460 ng.hr/ml, respectively. C-max of PPF was about 828.4 ng/ml and the peak concentration was achieved at about 2.2 hr (T-max) These results indicate that PPF is rapidly disappeared from blood due to extensive metabolism into PPFOH.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/09/20 alle ore 00:38:59